Hematologic Toxicity on RTOG 0418: A Phase II Study of Post-operative IMRT for Gynecologic Cancer

Reviewer: Lara Bonner Millar, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 3 de noviembre del 2010

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASTRO: Hypofractionated IMRT Practical Approach in Prostate CA

Sep 30, 2011

Hypofractionated intensity modulated radiation as effective as conventional IMRT at five years

ASTRO: Fewer Side Effects With IMRT for Prostate Cancer

Oct 4, 2011

Intensity modulated radiation therapy tied to fewer side effects than 3-D conformal radiation

Stereotactic Body Radiation Less Costly, More Toxic Than IMRT

Mar 19, 2014

SBRT linked to increased genitourinary toxicity in Medicare beneficiaries with prostate cancer

From the National Cancer Institute